CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS]
CPHI [CHINA PHARMAS,] SC 13G/A: CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS]
CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 13, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended]
CPHI [CHINA PHARMAS,] CORRESP: China Pharma Holdings, Inc. Second Floor, No. 17,
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 13, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended]
CPHI [CHINA PHARMAS,] CORRESP: China Pharmas, Second Floor, No. 17, Jinpan Road
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 13, 2012 VIA EDGAR Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]
CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 13, 2012 VIA EDGAR Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CPHI [CHINA PHARMAS,] SC 13G/A: reporting person’s initial filing on this form with
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CPHI [CHINA PHARMAS,] SC 13G/A: reporting person’s initial filing on this form with
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
